Identification of potential biomarkers and candidate therapeutic drugs for clear cell renal cell carcinoma by bioinformatic analysis and reverse network pharmacology.

Meng, Zhuo; Yuan, Bo; Yang, Shuang; Fu, Xiaotong; Zhang, Baoyue; Xu, Kun; Bao, Pengfei; Huang, Youliang

Meng, Zhuo; Yuan, Bo; Yang, Shuang; Fu, Xiaotong; Zhang, Baoyue; Xu, Kun; Bao, Pengfei; Huang, Youliang.

Afiliação

Meng Z; School of Management, Beijing University of Chinese Medicine, Beijing, China.
Yuan B; School of Management, Beijing University of Chinese Medicine, Beijing, China.
Yang S; Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing, China.
Fu X; Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Zhang B; Institute of Epidemiology and Health Care, University College London, London, UK.
Xu K; Peking University Medical library, Beijing, China.
Bao P; School of Economics and Management, Beijing Jiaotong University, Beijing, China.
Huang Y; School of Management, Beijing University of Chinese Medicine, Beijing, China.

Medicine (Baltimore) ; 102(35): e34929, 2023 Sep 01.

Article em En | MEDLINE | ID: mdl-37657024

Assuntos

Carcinoma de Células Renais; Carcinoma; Neoplasias Renais; Humanos; Carcinoma de Células Renais/tratamento farmacológico; Carcinoma de Células Renais/genética; Fator Neurotrófico Derivado do Encéfalo; Simulação de Acoplamento Molecular; Farmacologia em Rede; Biomarcadores; Biologia Computacional; Neoplasias Renais/tratamento farmacológico; Neoplasias Renais/genética; Membro 3 da Família 12 de Carreador de Soluto

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma / Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google